Royal Bank of Canada »

Revance Therapeutics shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2023-12-31 $789k 89k 8.84
2023-09-30 $745k 72k 10.31
2023-06-30 $1.1M 43k 25.32
2022-12-31 $1.2M 64k 18.44
2022-09-30 $1.4M 52k 27.00
2021-06-30 $947k 25k 38.46
2021-03-31 $823k 30k 27.87
2020-12-31 $1.2M 39k 30.00
2020-09-30 $636k 25k 25.14
2020-06-30 $592k 24k 24.44
2020-03-31 $358k 24k 14.81
2019-12-31 $392k 24k 16.06
2019-09-30 $404k 31k 13.00
2019-03-31 $422k 27k 15.77
2018-12-31 $488k 24k 20.14
2018-09-30 $657k 26k 25.49
2018-06-30 $704k 26k 27.46
2018-03-31 $816k 27k 30.81
2017-12-31 $916k 26k 35.75
2016-12-31 $428k 21k 20.62
2016-09-30 $317k 20k 16.23
2016-06-30 $261k 19k 13.58
2016-03-31 $353k 20k 17.46
2015-12-31 $197k 5.8k 34.14
2015-09-30 $41k 1.4k 29.73
2015-03-31 $13k 650 20.00
2014-12-31 $0 901 0.00
2014-09-30 $13k 650 20.00
2014-06-30 $888k 26k 33.99
2014-03-31 $353k 11k 31.52